Lassa
Fever Treatment Market: Introduction
Lassa
fever is a type of acute illness caused by a single-stranded RNA arena virus,
which belongs to the family Arenaviridae. It is a zoonotic disease, which means
humans are affected only when they are infected or when they come in contact
with the virus. Modes of transmission for this fever include coming in close
contact to rat excreta, rat’s blood, contaminated food and water. Fever,
general weakness, and malaise are a few initial symptoms of patients affected
with Lassa fever. Late symptoms of this disease include headache, sore throat,
muscle pain, chest pain, nausea, vomiting, diarrhea, cough, and abdominal pain
after some days. Rural areas and dwellings are more commonly affected due to
poor hygiene and sanitation facilities. Ribavirin, an antiviral drug, is
commonly used for the treatment of Lassa fever.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81748
Key
Drivers and Restraints of Global Lassa fever Treatment Market
·
Rise in number of patients affected with Lassa fever and its
increasing prevalence and gradual rise in the percentage mortality caused by
Lassa fever are key factors that drive the market. According to WHO, the
overall rate of fatality is 1% and observed fatality rate of patients
hospitalized with severe cases of Lassa fever is 15%. Late stages of Lassa
fever are more fatal than the initial stages.
·
Technological advancements such as multidisciplinary research
and development activities being carried out consistently for the development
of a novel drug, recent modifications in immunodiagnostics kits to enhance the
efficacy of current treatment options, and increasing public awareness about
Lassa fever are also major factors that are projected to boost the Lassa fever
market during the forecast period.
·
However lack of skilled professionals and manpower involved for
the treatment of Lassa fever, unavailability of healthcare infrastructure in
several regions due to unorganized sales and distribution, and the difficulty
to diagnose patients based on starting initial infection symptoms and clinical
presentations are likely to hamper the Lassa
fever treatment market during the forecast period.
Request COVID Analysis on Lassa Fever Treatment Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81748
Ribavirin
tablets segment to dominate the global Lassa fever treatment market
·
Based on dosage form, the global Lassa fever treatment market
can be divided into Ribavirin tablets, Ribavirin inhalation solution, and
Ribavirin oral solution
·
The Ribavirin tablets segment dominated the global market in
2019. It is projected to maintain its position during the forecast period due
to the ease in manufacturing and handling of tablets, increased flexibility and
compatibility, increased water solubility and easy absorption by the body. The
process involved in the manufacturing and handling of tablets is quite easy as
compared to inhalers and oral solutions. Tablets are highly soluble than
capsules, which cause them to act in a better way in absorption and
assimilation by the body. Increased flexibility of tablets means that these can
be taken with or without food. These factors, cumulatively, drive the segment.
Request customization on Lassa Fever Treatment Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=81748
Antiviral
treatment segment to hold prominent share of global Lassa fever treatment
market
·
Based on type of treatment, the global Lassa fever treatment
market can be classified into antiviral treatment, supportive care, and others
·
The antiviral treatment segment is estimated to hold a prominent
share of the global market, in terms of revenue, due to an increase in the
number of Lassa fever cases and its prevalence globally
Hospital pharmacies segment to expand significantly
·
Based on distribution channel, the global Lassa fever treatment
market can be split into hospital pharmacy, retail pharmacies, and e-commerce
pharmacies
·
The hospital pharmacies segment is projected to expand at a
higher growth due to prescribed and sometimes free consultation from doctor,
proper examination done at hospitals, and easy availability of medicines from
hospital pharmacies as compared to that from retail pharmacies.
North America is estimated to dominate the Global Lassa fever
treatment market
·
In terms of region, the global high Lassa fever treatment market
can be divided into North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa
·
Middle East & Africa is projected to hold a major share of
the global Lassa fever treatment market, in terms of revenue, due to an
increase in the number of Lassa fever cases and a large affected and diseased
patient pool present in Middle East & Africa. Furthermore, rise in disease
prevalence in emerging countries is expected to propel the Lassa fever
treatment market.
Pre Book Lassa Fever Treatment Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=81748<ype=S
Key
Manufacturers Operating in Market
The global
Lassa fever treatment market was highly fragmented in 2019. Key manufacturers
operating in the global market are:
·
Zydus Pharmaceuticals
·
Valeant Pharmaceuticals international
·
F. Hoffmann La Roche AG
·
Sandoz Inc. (Novartis AG)
·
Teva Pharmaceuticals
·
Three Rivers Pharmaceuticals LLC
·
Schering-Plough Research Institute
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders, consultants, and
strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve,
and mature. Our real-time data collection methods along with ability to track
more than one million high growth niche products are aligned with your aims.
The detailed and proprietary statistical models used by our analysts offer
insights for making right decision in the shortest span of time. For
organizations that require specific but comprehensive information we offer
customized solutions through adhoc reports. These requests are delivered with
the perfect combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with
right methodology of research is the key to help enterprises reach right
decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
